Instituto Valenciano de Oncologia

What Instituto Valenciano de Oncologia does

Instituto Valenciano de Oncología (IVO) is a private non-profit foundation founded in 1976 and headquartered in Valencia, Spain, operating as a monographic (cancer-only) hospital. It serves residents of the Valencian Community under a concerted action agreement with the Conselleria de Sanitat Universal i Salut Pública, delivering care at no direct cost to SIP-card holders with documented oncological suspicion, and additionally accepts private insurance patients with prior authorization. The foundation operates a multi-building hospital complex in Valencia plus radiotherapy satellite units in Alcoy (Comunidad Valenciana) and Cuenca (Castilla-La Mancha).

IVO's service offering covers the full cancer care pathway: early diagnosis units (breast, prostate, cervix, and the I-ELCAP lung program), robotic surgery using two Da Vinci Xi systems (the only Valencian Community center with this count since 2024), advanced radiotherapy (3D, IGRT, IMRT, radiosurgery, SBRT, LDR/HDR brachytherapy), systemic treatments (chemotherapy, hormone therapy, immunotherapy, molecular targeted drugs), nuclear medicine, genetic counseling, clinical trials, a biobank, multidisciplinary tumor committees across ten specialties, palliative care, psychological support, and home hospitalization. Patient-facing digital infrastructure includes a Patient Portal (portalpaciente.fivo.org) for appointments and medical reports.

Economically, IVO functions as a publicly-funded concerted center under multi-year regional contracts, supplemented by private insurance billing; as a non-profit foundation, all assets are reinvested into cancer prevention, diagnosis, treatment, research, and teaching. It runs a Formación Sanitaria Especializada (MIR-equivalent) training program and a Comisión de Docencia, embedding teaching into its operating model. No revenue, funding rounds, parent entity, or acquisition activity is publicly disclosed.

Name

Instituto Valenciano de Oncologia

Legal name

FUNDACIÓN INSTITUTO VALENCIANO DE ONCOLOGÍA

Website

https://ivo.es

Company type

Private

Founded year

1976

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Instituto Valenciano de Oncología (IVO) is a Valencia-based non-profit foundation and monographic oncology hospital founded in 1976, serving Valencian Community public-health patients under a concerted regional agreement and offering robotic surgery, radiotherapy, systemic therapy, and clinical research.

Ownership category

akta.pro rank

Product category

Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Offices of Physicians (62111)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Thoracic (Lung) Oncology (HLAKAFAL), Continuous Home Care (Crisis Hospice) (HSABAFAB)

Keywords

• Oncology hospital services
• Cancer treatment center
• Radiation therapy services
• Robotic cancer surgery
• Clinical oncology research

Headquarters

HQ city

Valencia

HQ country

Spain

HQ region

Europe

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Public Health System Reimbursement: IVO operates as a concerted center (centro concertado) with the public health system. Residents of the Valencian Community with SIP health card and documented oncological suspicion can receive treatment at no cost, as services are covered under the concerted action agreement with the Ministry of Universal Health and Public Health of the Valencian Community.
2. Private Insurance: Patients with private health insurance can also be treated at IVO with prior authorization from their insurance provider.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

IVO is a non-profit oncology hospital foundation that delivers comprehensive cancer care services including early diagnosis, robotic and conventional surgery, advanced radiotherapy, systemic treatments (chemotherapy, immunotherapy, hormone therapy, molecular targeted drugs), palliative care, and psychological support. It also operates multidisciplinary tumor committees, clinical trials, a biobank, and genetic counseling services across its main hospital complex in Valencia and satellite radiotherapy units in Alcoy and Cuenca.

Product overview

IVO (Instituto Valenciano de Oncología) is a private non-profit foundation established in 1976, operating as a specialized oncology hospital in Valencia, Spain. The institution offers a comprehensive cancer care ecosystem comprising multiple integrated services: robotic surgery using the Da Vinci Xi system (as the only center in the Valencian Community with two Da Vinci Xi units since 2024), advanced radiotherapy techniques (3D, IGRT, IMRT, radiosurgery, SBRT, brachytherapy), systemic treatments (chemotherapy, hormone therapy, immunotherapy, molecularly targeted drugs), early cancer diagnosis units, multidisciplinary tumor committees, clinical trials, genetic counseling, nuclear medicine, and home hospitalization. The hospital complex includes multiple specialized buildings and satellite radiotherapy units in Alcoy and Cuenca. Patient-facing digital services include a patient portal for appointment management and medical report access. The institution operates as a concerted center with public health agreements, providing services primarily to residents of the Valencian Community with public health coverage.

Differentiator

Problem solved

Functional benefit

Products and services

• Cirugía Robótica Da Vinci Xi (Robotic Surgery) Robotic-assisted minimally invasive surgery using two Da Vinci Xi systems, enabling surgeons to perform complex cancer procedures with high precision through small incisions, resulting in faster patient recovery. Intended for oncology patients requiring surgical treatment.
• Radioterapia (Radiotherapy) Comprehensive radiation therapy services including 3D External Radiotherapy, Image-Guided Radiation Therapy (IGRT), Intensity-Modulated Radiation Therapy (IMRT), Radiosurgery, Stereotactic Body Radiation Therapy (SBRT), Low Dose Rate Brachytherapy (LDR), and High Dose Rate Brachytherapy (HDR) for treatment of various cancer types. Intended for oncology patients requiring radiation-based treatment.
• Tratamientos Sistémicos (Systemic Cancer Treatments) Systemic cancer treatments including chemotherapy, hormone therapy, immunotherapy, and molecularly targeted drugs (monoclonal antibodies, tyrosine kinase inhibitors, cell cycle inhibitors, proteasome inhibitors, antiangiogenic drugs, vaccines). Intended for oncology patients requiring systemic pharmacological therapy.
• Unidades de Diagnóstico Precoz (Early Cancer Diagnosis Units) Early cancer screening units providing diagnostic services for breast, prostate, cervix, and lung cancers, including the I-ELCAP (International Early Lung Cancer Action Program) unit. Intended for individuals seeking early cancer detection and screening.
• Comités de Tumores (Multidisciplinary Tumor Committees) Multidisciplinary committees composed of expert physicians from main oncological specialties (head and neck, brain, digestive, gynecological, hematological, breast, melanoma, lung, sarcoma, urological) that define individualized therapeutic strategies for each patient. Intended for cancer patients requiring complex treatment planning.
• Ensayos Clínicos (Clinical Trials Program) Clinical trials program providing patients with access to innovative cancer treatments under investigation. Intended for oncology patients seeking experimental or emerging treatment options.
• Biobanco (Biobank) Biobank service for storing biological samples used in cancer research. Intended for supporting translational oncology research activities.
• Consejo Genético (Genetic Counseling) Genetic counseling service for patients with family history of cancer to assess hereditary risk and inform preventive strategies. Intended for individuals with familial cancer risk concerns.
• Medicina Nuclear (Nuclear Medicine) Nuclear medicine diagnostic and therapeutic services using radioactive isotopes for cancer imaging and targeted treatment. Intended for oncology patients requiring specialized diagnostic imaging or radionuclide therapy.
• Hospitalización Domiciliaria (Home Hospitalization) Home hospitalization service allowing cancer patients to receive treatment and care in the comfort of their homes. Intended for oncology patients who can be safely managed in a home-based setting.

Quantifiable outcome

• 50 years of experience in cancer treatment since 1976
• +1 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Conselleria de Sanitat Universal i Salut Pública de la Comunitat ValencianacoreStrategic or Co-development Partner · 1 January 1976IVO maintains a concerted action agreement (acuerdo de acción concertada) with the Ministry of Universal Health and Public Health of the Valencian Community. Under this agreement, residents of the Valencian Community with SIP health cards and documented oncological suspicion can receive treatment at the IVO at no cost, with the public health system covering the expenses.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• MD Anderson Cancer Center: Global benchmark monographic cancer center. Comparable to IVO as a specialty-only cancer institution spanning care, research, and teaching, but operating at vastly larger scale and global reach.
• Gustave Roussy: Leading French comprehensive cancer center combining hospital care, research, and teaching at significantly larger scale. Comparable as a European monographic oncology powerhouse, but operates at broader geographic and academic scale than IVO.
• Hospital Quirónsalud (Oncology services): Spain's largest private hospital group with oncology programs across multiple sites. Comparable to IVO in Spanish oncology delivery, but as a broad private incumbent rather than a monographic non-profit foundation.
• Charité Comprehensive Cancer Center: Berlin-based university cancer center within Charité, Europe's largest university hospital. Comparable as a European comprehensive oncology program with research and multidisciplinary tumor boards, though embedded in a broader academic hospital.

Direct peers

• Istituto Nazionale dei Tumori (INT Milan): Italian public comprehensive cancer center combining patient care, translational research, and teaching. Comparable to IVO as a publicly-funded European monographic oncology institution with hospital, research, and clinical trial operations.
• Hospital Clínic de Barcelona - Oncología: Barcelona university hospital with active oncology, radiotherapy, and clinical trial programs. Comparable to IVO in Spanish public-system cancer care delivery, though as part of a broader general hospital.
• Hospital Universitario Vall d'Hebron - Oncología: Large Barcelona university hospital with a comprehensive oncology program, multidisciplinary tumor boards, and research infrastructure. Comparable to IVO in offering integrated oncology care within Spain, though embedded in a general hospital rather than a stand-alone foundation.
• Istituto Europeo di Oncologia (IEO): Milan-based monographic cancer hospital focused exclusively on oncology with research and teaching missions. Closely matches IVO's monographic specialty model, integrated research infrastructure, and European public-system exposure.
• Institut Català d'Oncologia (ICO): Public monographic oncology center network in Catalonia providing comprehensive cancer diagnosis, treatment, and research. Directly comparable to IVO as a regionally-anchored, publicly-funded Spanish specialty cancer hospital.

Regional players

• Hospital Universitario 12 de Octubre (Oncología): Madrid public university hospital with comprehensive oncology and radiotherapy services. Comparable to IVO in Spanish public-system oncology delivery, though anchored in Madrid rather than the Valencian Community.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UC8yQOSWpbRRHb46dNLDEvwQ/videos
• LinkedInlinkedin.com/company/fundaci%C3%B3n-instituto-valenciano-de-oncolog%C3%ADa-ivo

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Instituto Valenciano de Oncologia